Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow

被引:36
作者
Abdelrahim, M. E. [1 ,2 ]
Assi, K. H. [2 ]
Chrystyn, H. [3 ]
机构
[1] Univ Beni Suef, Fac Pharm, Bani Suwayf, Egypt
[2] Univ Bradford, Inst Pharmaceut Innovat, Bradford BD7 1DP, W Yorkshire, England
[3] Univ Huddersfield, Sch Appl Sci, Div Pharm & Pharmaceut Sci, Huddersfield HD1 3DH, W Yorkshire, England
关键词
Terbutaline; Turbuhaler; total emitted dose; aerodynamic characters; inhalation flow rate; DRY POWDER INHALERS; LUNG DEPOSITION; DELIVERY CHARACTERISTICS; SALBUTAMOL; BUDESONIDE; ASTHMATICS; DISKUS;
D O I
10.3109/10837450.2011.620970
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previously, dose emission below 30 L min(-1) through DPI has not been routinely determined. However, during routine use some patients do not achieve 30 L min(-1) inhalation flows. Hence, the aim of the present study was to determine dose emission characteristics for low inhalation flows from terbutaline sulphate Turbuhaler. Total emitted dose (TED), fine particle dose (FPD) and mass median aerodynamic diameter (MMAD) of terbutaline sulphate Turbuhaler were determined using inhalation flows of 10-60 L min(-1) and inhaled volume of 4 L. TED and FPD increase significantly with the increase of inhalation flows (p < 0.05). Flows had more pronounced effect on FPD than TED, thus, faster inhalation increases respirable amount more than it increases emitted dose. MMAD increases with decrease of inhalation flow until flow of 20L min(-1) then it decreases. In vitro flow dependent dose emission has been demonstrated previously for Turbuhaler for flow rates above 30 L min(-1) but is more pronounced below this flow. Minimal FPD below 30 L min(-1) suggests that during routine use at this flow rate most of emitted dose will impact in mouth. Flow dependent dose emission results suggest that Pharmacopoeias should consider the use variety of inhalation flows rather than one that is equivalent to pressure drop of 4 KPa.
引用
收藏
页码:944 / 949
页数:6
相关论文
共 27 条
  • [1] Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions
    Abdelrahim, Mohamed E.
    [J]. RESPIRATORY MEDICINE, 2010, 104 (05) : 682 - 689
  • [2] [Anonymous], AM J RESP CRIT CARE
  • [3] The inhalation device influences lung deposition and bronchodilating effect of terbutaline
    Borgstrom, L
    Derom, E
    Stahl, E
    WahlinBoll, E
    Pauwels, R
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (05) : 1636 - 1640
  • [4] LUNG DEPOSITION OF BUDESONIDE INHALED VIA TURBUHALER(R) - A COMPARISON WITH TERBUTALINE SULFATE IN NORMAL SUBJECTS
    BORGSTROM, L
    BONDESSON, E
    MOREN, F
    TROFAST, E
    NEWMAN, SP
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (01) : 69 - 73
  • [5] *BRIT PHARM, 2005, PREP INH AER ASS FIN, pA277
  • [6] Inhalation profiles in asthmatics and COPD patients: Reproducibility and effect of instruction
    Broeders, MEAC
    Molema, J
    Hop, WCJ
    Folgering, HTM
    [J]. JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2003, 16 (02): : 131 - 141
  • [7] PEAK INSPIRATORY FLOW-THROUGH TURBUHALER(R) IN ACUTE ASTHMA
    BROWN, PH
    NING, ACWS
    GREENING, AP
    MCLEAN, A
    CROMPTON, GK
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (11) : 1940 - 1941
  • [8] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    Calverley, P
    Pauwels, R
    Vestbo, J
    Jones, P
    Pride, N
    Gulsvik, A
    Anderson, J
    Maden, C
    [J]. LANCET, 2003, 361 (9356) : 449 - 456
  • [9] Is inhalation rate important for a dry powder inhaler? using the In-Check Dial to identify these rates
    Chrystyn, H
    [J]. RESPIRATORY MEDICINE, 2003, 97 (02) : 181 - 187
  • [10] European Pharmacopeia, 2002, PREP INH AER ASS FIN, P209